Solicitation of Nominations for Appointment to the Advisory Committee on Breast Cancer in Young Women (ACBCYW), 64223-64224 [2022-23011]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 87, Number 204 (Monday, October 24, 2022)]
[Notices]
[Pages 64223-64224]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23011]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the Advisory 
Committee on Breast Cancer in Young Women (ACBCYW)

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) is 
seeking nominations for membership on the ACBCYW. The ACBCYW consists 
of 15 experts in fields associated with breast cancer, disease 
prevention, early detection, diagnosis, public health, social 
marketing, genetic screening and counseling, treatment, rehabilitation, 
palliative care, and survivorship in young women, or in related 
disciplines with a specific focus on young women.

DATES: Nominations for membership on the ACBCYW must be received no 
later than December 29, 2022. Packages received after this time will 
not be considered for the current membership cycle.

ADDRESSES: All nominations should be mailed to Kimberly E. Smith, MBA, 
MHA. c/o ACBCYW Secretariat, Centers

[[Page 64224]]

for Disease Control and Prevention, 3719 North Peachtree Road, Building 
100, Chamblee, Georgia 30341, or emailed (recommended) to 
[email protected].

FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, MBA, MHA, 
Designated Federal Officer, National Center for Chronic Disease 
Prevention and Health Promotion, CDC, 4770 Buford Highway NE, Mailstop 
S107-4, Atlanta, Georgia 30341; 404-498-0073; [email protected].

SUPPLEMENTARY INFORMATION: Nominations are being sought for individuals 
who have expertise and qualifications necessary to contribute to the 
accomplishments of the committee's objectives. Nominees will be 
selected based on expertise in the fields of breast health, breast 
cancer, disease prevention and risk reduction, survivorship (including 
metastatic breast cancer), hereditary breast and ovarian cancer, or in 
related disciplines with a specific focus on young women. Persons with 
personal experience with early onset breast cancer are also eligible to 
apply. This includes, but may not be limited to breast cancer survivors 
<45 years of age and caregivers of said persons. Federal employees will 
not be considered for membership. Members may be invited to serve up to 
four-year terms.
    Selection of members is based on candidates' qualifications to 
contribute to the accomplishment of ACBCYW objectives https://www.cdc.gov/maso/facm/facmacbcyw.html.
    The U.S. Department of Health and Human Services policy stipulates 
that committee membership be balanced in terms of points of view 
represented, and the committee's function. Appointments shall be made 
without discrimination on the basis of age, race, ethnicity, gender, 
sexual orientation, gender identity, HIV status, disability, and 
cultural, religious, or socioeconomic status. Nominees must be U.S. 
citizens, and cannot be full-time employees of the U.S. Government. 
Current participation on federal workgroups or prior experience serving 
on a federal advisory committee does not disqualify a candidate; 
however, HHS policy is to avoid excessive individual service on 
advisory committees and multiple committee memberships. Committee 
members are Special Government Employees, requiring the filing of 
financial disclosure reports at the beginning and annually during their 
terms. CDC reviews potential candidates for ACBCYW membership each 
year, and provides a slate of nominees for consideration to the 
Secretary of HHS for final selection. HHS notifies selected candidates 
of their appointment near the start of the term in November 2023, or as 
soon as the HHS selection process is completed. Note that the need for 
different expertise varies from year to year and a candidate who is not 
selected in one year may be reconsidered in a subsequent year. Nominees 
must be U.S. citizens, and cannot be full-time employees of the U.S. 
Government. Candidates should submit the following items:
    [ssquf] Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address).
    [ssquf] At least one letter of recommendation from person(s) not 
employed by the U.S. Department of Health and Human Services. 
(Candidates may submit letter(s) from current HHS employees if they 
wish, but at least one letter must be submitted by a person not 
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
    [ssquf] A short biography (150 words or less).
    Nominations may be submitted by the candidate him- or herself, or 
by the person/organization recommending the candidate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-23011 Filed 10-21-22; 8:45 am]
BILLING CODE 4163-18-P